Estradiol affects liver mitochondrial function in ovariectomized and tamoxifen-treated ovariectomized female rats

Toxicology and Applied Pharmacology

Volumn 221, Issue 1, 2007, Pages 102-110

  Moreira, Paula I ^a,b   Custódio, José B A ^a,c   Nunes, Elsa ^a,b   Moreno, António ^a,d,e   Seiça, Raquel ^a,b   Oliveira, Catarina R ^a,b   Santos, Maria S ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

17 Estradiol; Mitochondria; Ovariectomy; Oxidative phosphorylation system; Oxidative stress; Respiratory chain; Tamoxifen

Indexed keywords

ESTRADIOL; HYDROGEN PEROXIDE; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; LIPID PEROXIDATION; LIVER MITOCHONDRION; MEMBRANE PERMEABILITY; MENOPAUSE; NONHUMAN; OVARIECTOMY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RAT; RESPIRATORY CHAIN;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CALCIUM; ESTRADIOL; FEMALE; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OVARIECTOMY; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RATS; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 34247869542     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.02.006     Document Type: Article

References (57)

1. Barja G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J. Bioenerg. Biomembr. 31 (1999) 347-366
2. Borras C., Sastre J., Garcia-Sala D., Lloret A., Pallardo F.V., and Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radical Biol. Med. 34 (2003) 546-552
3. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol. Chem. 387 (2006) 1329-1335
4. Boyd C.S., and Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol. Chem. 383 (2002) 411-423
5. Cardoso C.M., Almeida L.M., and Custodio J.B. 4-Hydroxytamoxifen is a potent inhibitor of the mitochondrial permeability transition. Mitochondrion 1 (2002) 485-495
6. Chance B., and Williams G.R. Respiratory enzymes in oxidative phosphorylation. VI. The effects of adenosine diphosphate on azide-treated mitochondria. J. Biol. Chem. 221 (1956) 477-489
7. Custodio J.B., Almeida L.M., and Madeira V.M. A reliable and rapid procedure to estimate drug partitioning in biomembranes. Biochem. Biophys. Res. Commun. 176 (1991) 1079-1085
8. Custodio J.B., Almeida L.M., and Madeira V.M. The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes. Biochim. Biophys. Acta 1153 (1993) 308-314
9. Custodio J.B., Dinis T.C., Almeida L.M., and Madeira V.M. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol. 47 (1994) 1989-1998
10. 2+ and inorganic phosphate. Toxicol. Appl. Pharmacol. 152 (1998) 10-17
11. Czerny B., Pawlik A., Teister M., Juzyszyn Z., and Mysliwiec Z. Effect of tamoxifen and raloxifene on cholesterol transformation to bile acids in ovariectomized rats. Gynecol. Endocrinol. 20 (2005) 313-316
12. Dayspring T., Qu Y., and Keech C. Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia. Metabolism 55 (2006) 972-979
13. Duchen M.R. Mitochondria in health and disease; perspectives on a new mitochondrial biology. Mol. Aspects Med. 25 (2004) 365-451
14. El-Beshbishy H.A. Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen-induced liver injury in rats. J. Biochem. Mol. Biol. 38 (2005) 563-570
15. Estabrook R.E. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol. 10 (1967) 41-47
16. Felty Q., and Roy D. Estrogen, mitochondria, and growth of cancer and non-cancer cells. J. Carcinog. 4 (2005) 1
17. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15 (2003) 247-254
18. Fromson J.M., Pearson S., and Bramah S. The metabolism of tamoxifen (I C.I. 46,474): II. In female patients. Xenobiotica 3 (1973) 711-714
19. Gazotti P., Malmstron K., and Crompton M. A Laboratory Manual on Transport and Bioenergetics (1979), Springer Verlag, New York
20. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177 (1949) 751-766
21. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
22. Kamo N., Muratsugu M., Hongoh R., and Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 49 (1979) 105-121
23. Katzenellenbogen J.A., O'Malley B.W., and Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10 (1996) 119-131
24. Kumru S., Aydin S., Aras A., Gursu M.F., and Gulcu F. Effects of surgical menopause and estrogen replacement therapy on serum paraoxonase activity and plasma malondialdehyde concentration. Gynecol. Obstet. Invest. 59 (2005) 108-112
25. Kwan K., Ward C., and Marsden J. Is there a role for hormone replacement therapy after breast cancer?. J. Br. Menopause Soc. 11 (2005) 140-144
26. Lim Y.C., Li L., Desta Z., Zhao Q., Rae J.M., Flockhart D.A., and Skaar T.C. Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells. J. Pharmacol. Exp. Ther. 318 (2006) 503-512
27. Liu C.L., Huang J.K., Cheng S.P., Chang Y.C., and Liu J.J. Fatty liver and transaminase changes with adjuvant tamoxifen therapy. Anti-cancer Drugs 17 (2006) 709-713
28. Lopez M., Lelliott C.J., Tovar S., Kimber W., Gallego R., Virtue S., Blount M., Vazquez M.J., Finer N., Powles T.J., O'Rahilly S., Saha A.K., Dieguez C., and Vidal-Puig A.J. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55 (2006) 1327-1336
29. 2-induced endothelial cell apoptosis. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E585-E593
30. McCray P.B., Gibson D.D., Fong K.L., and Hornbrook K.R. Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochim. Biophys. Acta 431 (1979) 459-468
31. McDonnell D.P. Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen. J. Soc. Gynecol. Investig. 7 (2000) S10-S15
32. Moats II R.K., and Ramirez V.D. Rapid uptake and binding of estradiol-17beta-6-(O-carboxymethyl)oxime:125I-labeled BSA by female rat liver. Biol. Reprod. 58 (1998) 531-538
33. Moreira P.I., Custodio J.B., Oliveira C.R., and Santos M.S. Hydroxytamoxifen protects against oxidative stress in brain mitochondria. Biochem. Pharmacol. 68 (2004) 195-204
34. Moreira P.I., Custodio J.B., Oliveira C.R., and Santos M.S. Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen. Neuropharmacology 48 (2005) 435-447
35. Moreira P.I., Custodio J., Moreno A., Oliveira C.R., and Santos M.S. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J. Biol. Chem. 281 (2006) 10143-10152
36. Muratsugu M., Kamo N., Kurihara K., and Kobatake Y. Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in biological systems. Biochim. Biophys. Acta 464 (1977) 613-619
37. Nilsen J., Chen S., Irwin R.W., Iwamoto S., and Brinton R.D. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 7 (2006) 74
38. Oztekin E., Tiftik A.M., Baltaci A.K., and Mogulkoc R. Lipid peroxidation in liver tissue of ovariectomized and pinealectomized rats: effect of estradiol and progesterone supplementation. Cell Biochem. Funct. (2006) 10.1002/cbf.1313
39. Oztekin E., Baltaci A.K., Tiftik A.M., and Mogulkoc R. Lipid peroxidation in ovariectomized and pinealectomized rats: the effects of estradiol and progesterone supplementation. Cell Biochem. Funct. (2006) 10.1002/cbf.1360
40. Parkash J., Felty Q., and Roy D. Estrogen exerts a spatial and temporal influence on reactive oxygen species generation that precedes calcium uptake in high-capacity mitochondria: implications for rapid nongenomic signaling of cell growth. Biochemistry 45 (2006) 2872-2881
41. Petrovic S., Demajo M., and Horvat A. Estradiol affects calcium transport across mitochondrial membrane in different brain regions. Ann. N. Y. Acad. Sci. 1048 (2005) 341-343
42. Rajdev S., and Reynolds I.J. Calcium green-5N, a novel fluorescent probe for monitoring high intracellular free Ca2+ concentrations associated with glutamate excitotoxicity in cultured rat brain neurons. Neurosci. Lett. 162 (1993) 149-152
43. Richardson D.N. The history of Nolvadex. Drug Des. Delivery 3 (1988) 1-14
44. Santos M.S., Santos D.L., Palmeira C.M., Seiça R., Moreno A.J., and Oliveira C.R. Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab. Res. Rev. 17 (2001) 223-230
45. Sato M., Rippy M.K., and Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 10 (1996) 905-912
46. van Seumeren I.V. Weight gain and hormone replacement therapy: are women's fears justified?. Maturitas 34 (2000) S3-S8
47. Storz P. Reactive oxygen species-mediated mitochondria-to-nucleus signaling: a key to aging and radical-caused diseases. Sci. STKE (2006) re3
48. Tsuchiya Y., Nakajima M., and Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 227 (2005) 115-124
49. Vina J., Sastre J., Pallardo F., and Borras C. Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid. Redox Signal. 5 (2003) 549-556
50. Vinogradov A., Scarpa A., and Chance B. Calcium and pyridine nucleotide interaction in mitochondrial membranes. Arch. Biochem. Biophys. 152 (1972) 646-654
51. Wade G.N., and Heller H.W. Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. Am. J. Physiol. 264 (1993) R1219-R1223
52. Wallace K.B., and Starkov A.A. Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 353-388
53. Wingrove D.E., and Gunter T.E. Kinetics of mitochondrial calcium transport. II. A kinetic description of the sodium-dependent calcium efflux mechanism of liver mitochondria and inhibition by ruthenium red and by tetraphenylphosphonium. J. Biol. Chem. 261 (1986) 15166-15171
54. 2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 70 (2006) 395-404
55. Yang S.H., Liu R., Perez E.J., Wen Y., Stevens Jr. S.M., Valencia T., Brun-Zinkernagel A.M., Prokai L., Will Y., Dykens J., Koulen P., and Simpkins J. Mitochondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4130-4135
56. Zheng J., and Ramirez V.D. Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase. J. Steroid. Biochem. Mol. Biol. 68 (1999) 65-75
57. Zoratti M., and Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1241 (1995) 139-176